Teva Pharmaceutical Industries (TEVA) Tax Rate (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Tax Rate came in at 26.59% in Q2 2026, up 1183.0% YoY from 2.07% in Q2 2025, and down 273.45% on a QoQ basis from 15.33% in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Tax Rate (2009 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 18 years of Tax Rate data on file, last reported at 26.59% in Q2 2026.
- Quarterly Tax Rate rose 1183.0% year-over-year to 26.59% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 1.69% (up 12737.0% YoY) and the FY2025 annual result came in at 14.72%, up 3793.0% from the prior year.
- Tax Rate fell to 26.59% in Q2 2026, from 15.33% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 76.4% in Q2 2022 to a low of 487.5% in Q4 2025.
- A 5-year average of 36.94% and a median of 6.74% in 2023 frame the typical range for Tax Rate.
- The widest YoY moves for Tax Rate: up 21767 bps in 2025, down 47616 bps in 2025.
- Tracing TEVA's Tax Rate over 5 years: stood at 12.57% in 2022, then surged by 81 bps to 2.34% in 2023, then slumped by 385 bps to 11.34% in 2024, then plunged by 4200 bps to 487.5% in 2025, then surged by 95 bps to 26.59% in 2026.
- The last three Tax Rate figures came in at 26.59% (Q2 2026), 15.33% (Q1 2026), and 487.5% (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.64 Bn | 2.15 Bn | -26.59% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.74 Bn | 22.95 Bn | 5.10 Bn | -30.40% |
| 5 | United Therapeutics | 22.26 Bn | 19.60 Bn | 683.80 Mn | 10.65% |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | -85.63% |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 10.97% |
| 8 | Elanco Animal Health | 12.15 Bn | 11.62 Bn | 798.00 Mn | 3.57% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.28 Bn | 7.62 Bn | 397.90 Mn | 127.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.59% |
| Jun 30, 2026 | -26.59% |
| Jun 30, 2026 | -26.59% |
| Mar 31, 2026 | 15.33% |
| Mar 31, 2026 | 15.33% |
| Mar 31, 2026 | 15.33% |
| Dec 31, 2025 | -487.50% |
| Dec 31, 2025 | -487.50% |
| Dec 31, 2025 | -487.50% |
| Sep 30, 2025 | 33.13% |
| Sep 30, 2025 | 33.13% |
| Sep 30, 2025 | 33.13% |
| Jun 30, 2025 | -38.42% |
| Jun 30, 2025 | -38.42% |
| Jun 30, 2025 | -38.42% |
| Mar 31, 2025 | 25.17% |
| Mar 31, 2025 | 25.17% |
| Mar 31, 2025 | 25.17% |
| Dec 31, 2024 | -11.34% |
| Dec 31, 2024 | -11.34% |